X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Drug Design Development and Therapy

期刊標題檢索 DRUG DES DEV TH 最新評論: Have you rushed the editors? (2024-05-13)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Drug Design Development and Therapy]您好,您是該頁面的第 132321 位訪客。

期刊簡介
期刊名稱Drug Design Development and Therapy Drug Design Development and Therapy
LetPub Score
6.9
50 ratings
Rate

Reputation
7.4

Influence
5.9

Speed
9.1

期刊簡稱DRUG DES DEV THER
ISSN1177-8881
h-index48
CiteScore
CiteScoreSJRSNIPCiteScore Rank
9.000.9991.124
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q124 / 183
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q148 / 313
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Drug Discovery
Q127 / 157

自引率 (2023-2024)2.10%自引率趨勢
掲載範囲
Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications.

The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas.

Specific topics covered by the journal include:

Drug target identification and validation
Phenotypic screening and target deconvolution
Biochemical analyses of drug targets and their pathways
New methods or relevant applications in molecular/drug design and computer-aided drug discovery*
Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes)
Structural or molecular biological studies elucidating molecular recognition processes
Fragment-based drug discovery
Pharmaceutical/red biotechnology
Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products**
Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development
Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing)
Preclinical development studies
Translational animal models
Mechanisms of action and signalling pathways
Toxicology
Gene therapy, cell therapy and immunotherapy
Personalized medicine and pharmacogenomics
Clinical drug evaluation
Patient safety and sustained use of medicines.
官方網站https://www.dovepress.com/drug-design-development-and-therapy-journal
在線稿件提交https://www.dovepress.com/submit_step_1.php
開放訪問Yes
出版商Dove Medical Press Ltd.
主題領域CHEMISTRY, MEDICINAL
出版國/地區ENGLAND
發行頻率
創刊年2007
每年文章數256每年文章數趨勢
黃金OA百分比97.50%
OA Related Info
APC: Yes( USD3300; )
APC waiver:Check Notes
Other charges: No
Keywords: drug design、drug safety、drug development、pharmaecuticals
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CHEMISTRY, MEDICINALSCIEQ117/72
PHARMACOLOGY & PHARMACYSCIEQ155/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1177-8881%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Drug Design Development and Therapy】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    International Journal of NanomedicineH-index: 100

    CiteScore: 14.40
    Drug Delivery and Translational ResearchH-index: 27

    CiteScore: 11.70
    Chinese MedicineH-index: 34

    CiteScore: 7.90
    International Journal for Parasitology-Drugs and Drug ResistanceH-index: 27

    CiteScore: 7.90
    Chinese Journal of Natural MedicinesH-index: 27

    CiteScore: 7.50
    Journal of Global Antimicrobial ResistanceH-index: 16

    CiteScore: 8.70
    Australian PrescriberH-index: 21

    CiteScore: 3.80
    PEDIATRIC DRUGSH-index: 55

    CiteScore: 7.20
    Expert Review of NeurotherapeuticsH-index: 63

    CiteScore: 7.00
    Clinical Psychopharmacology and NeuroscienceH-index: 22

    CiteScore: 4.70
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Nanomedicine319614
    Chinese Medicine129945
    Chinese Journal of Natural Medicines101544
    Drug Delivery and Translational Research42335
    Iranian Journal of Basic Medical Sciences36011
    Journal of Global Antimicrobial Resistance33199
    PHARMACEUTICAL CHEMISTRY JOURNAL26689
    JOURNAL OF INFECTION AND CHEMOTHERAPY23403
    Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy15961
    International Journal for Parasitology-Drugs and Drug Resistance15052
  •  

    Drug Design Development and Therapy Drug Design Development and Therapy
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/16)
  [Drug Design Development and Therapy] 的評論撰寫評論
作者: 小长猫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-13 17:34:36 評論於
Have you rushed the editors?
(0) 讚! | 小长猫

作者: 小长猫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-07 14:36:46 評論於
What's the difference between 1a-1 and 1a-2? Has your status changed?
(0) 讚! | 小长猫

作者: 那新_


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-25 22:36:57 評論於
Hello, has your article gone through the stage of Peer reviewer(s) second round completed after revision? How long does it usually take?
(0) 讚! | 那新_

作者: 西柚果汁


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-04-24 18:59:43 評論於
2024.1.4 Submission created
2024.2.13 Editing check completed, moved to compliance check
          (Grammar revision and plagiarism check provided by the journal, revision required for a plagiarism score of more than 30; original protein bands need to be provided)
2024.2.14 Peer review starts
2024.2.22 First review result obtained
2024.3.7 Second review result obtained
2024.3.12 Revision email notification
2024.3.22 Revised
2024.4.18 Accepted
(0) 讚! | 西柚果汁

作者: supsci


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-23 10:16:45 評論於
4.23 now, still in 1A2 status
(0) 讚! | supsci

作者: supsci


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-23 10:16:06 評論於
4.23 now, still 1A2
(0) 讚! | supsci

作者: 吉航张


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-16 13:39:16 評論於
Submitted on March 5th, also 1A-2
(0) 讚! | 吉航张

作者: supsci


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-15 14:30:27 評論於
Submitted on March 5th, today is April 15th, still in status 1A_2 - INITIAL ASSESSMENT IN PROGRESS, it's indeed a bit slow
(0) 讚! | supsci

作者: 玄虚英叡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-11 10:13:51 評論於
What stage are you at now? Do they send emails to remind you in Stage 1A?
(0) 讚! | 玄虚英叡

作者: 玄虚英叡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-24 14:31:29 評論於
What was the previous state of your 1A?
(0) 讚! | 玄虚英叡

作者: 拂柳俊雄


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-23 21:31:23 評論於
But my 1A has been 20 days, I don't know what's going on
(0) 讚! | 拂柳俊雄

作者: 拂柳俊雄


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-23 14:22:19 評論於
It has been 20 days already, I am worried
(0) 讚! | 拂柳俊雄

作者: ZJQ


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-01-17 17:21:58 評論於
Please translate the following paragraph into English and Japanese, and provide translations under the headings "English Translation:" and "Japanese Translation:"
(130) 讚! | ZJQ

作者: 玄虚英叡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-15 16:52:33 評論於
How long have you been waiting to transform?
(0) 讚! | 玄虚英叡

作者: 晨风凌玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-17 16:57:48 評論於
I want to know how long 2A can last the longest. I have been lasting for 17 days and still inviting reviewers. I can't wait to graduate
(0) 讚! | 晨风凌玉

作者: 凌雪酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-02 19:30:12 評論於
Hello! I would like to ask whether the WB full film refers to a complete membrane or specific protein bands cut and incubated with certain antibodies after cutting
(0) 讚! | 凌雪酱大魔王

作者: 木子rj


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-29 17:44:18 評論於
Are you asking if we need to upload the raw data from wb three times?
(0) 讚! | 木子rj

作者: 犬走白筠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-20 09:04:05 評論於
"Same question, how do you upload the data for the reagent kit?"
(0) 讚! | 犬走白筠

作者: 犬走白筠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-19 15:15:38 評論於
Research focus: Pharmacological experience sharing: Do we need to upload data such as reagent kits besides WB? I want to upload but I didn't find the author's instructions on this part
(0) 讚! | 犬走白筠

作者: 通幽瑞彩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-01 10:33:38 評論於
About 10 days
(0) 讚! | 通幽瑞彩

作者: 西风庆叶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-25 10:30:47 評論於
How long does 1A last? It has been two weeks already
(0) 讚! | 西风庆叶

作者: 西风庆叶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-24 19:05:45 評論於
How long is the 1A status?
(0) 讚! | 西风庆叶

作者: 通幽瑞彩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-12 23:13:23 評論於
Today has finally changed, from the 4th to the 13th
(0) 讚! | 通幽瑞彩

作者: 通幽瑞彩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-12 21:29:47 評論於
My hand is itchy, it's size 4 to 12
(0) 讚! | 通幽瑞彩

作者: 通幽瑞彩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-12 09:19:59 評論於
About 10 days
(0) 讚! | 通幽瑞彩

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/16)

開始撰寫 [Drug Design Development and Therapy] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*